Interleukin-10 limits the expansion of immunoregulatory CD4 CD8 T cells in autoimmune-prone non-obese diabetic mice

Immunology and Cell Biology

Volumn 88, Issue 8, 2010, Pages 771-780

  Hillhouse, Erin E ^a,b   Beauchamp, Claudine ^a,b   Chabot Roy, Geneviève ^a   Dugas, Véronique ^a,b   Lesage, Sylvie ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

autoimmune diabetes; IL 10; immune regulation; T cells; transgenic mice

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CD4 CD8 RATIO; CELL EXPANSION; CELL STIMULATION; DENDRITIC CELL; DIABETES MELLITUS; DISEASE PREDISPOSITION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

MUS; MUS MUSCULUS;

EID: 78649325314     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.84     Document Type: Article

References (55)

1. Qin HY, Mukherjee R, Lee-Chan E, Ewen C, Bleackley RC, Singh B. A novel mechanism of regulatoryT cell-mediated down-regulation of autoimmunity. Int Immunol2006;18: 1001-1015.
2. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006; 25: 195-201.
3. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today2000; 21: 573-583.
4. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M etal. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(\)CD8\double-negative regulatory T cells. Blood 2005; 105: 2828-2835.
5. Zhang ZX, Ma Y, Wang H, Arp J, Jiang J, Huang X et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, fas-fas ligand-independent pathway. J Immunol 2006; 177: 6920-6929.
6. Bruno L, Fehling HJ, von Boehmer H. The alpha beta Tcell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells. Immunity 1996;5:343-352.
7. Caveno J, Zhang Y, Motyka B, Teh SJ, Teh HS. Functional similarity and differences between selection-independent CD4-CD8\alphabeta T cells and positively selected CD8T cells expressing the same TCR and the induction of anergy in CD4-CD8\alphabeta T cells in antigen-expressing mice. J Immunol 1999; 163: 1222-1229.
8. Fritsch M, Andersson A, Petersson K, Ivars F. A TCR alpha chain transgene induces maturation of CD4\CD8\alpha beta+ T cells from gamma delta T cell precursors. Eur J Immunol 1998; 28: 828-837.
9. Lesage S, Hartley SB, Akkaraju S, Wilson J, Townsend M, Goodnow CC. Failure to censor forbidden clones of CD4T cells in autoimmune diabetes. J Exp Med 2002; 196: 1175-1188.
10. Terrence K, Pavlovich CP, Matechak EO, Fowlkes BJ. Premature expression of T cell receptor (TCR)alphabeta suppresses TCRgammadelta gene rearrangement but permits development of gammadelta lineage T cells. J Exp Med 2000; 192: 537-548.
11. Viret C, Janeway Jr CA. Self-specific MHC class II-restricted CD4-CD8\T cells that escape deletion and lack regulatory activity. J Immunol 2003; 170: 201-209.
12. von Boehmer H, Kirberg J, Rocha B. An unusual lineage of alpha/beta T cells that contains autoreactive cells. J Exp Med 1991; 174: 1001-1008.
13. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously unknown antigen-specific regulatory Tcell and its mechanism of suppression. Nat Med 2000; 6: 782-789.
14. Young KJ, Yang L, Phillips MJ, Zhang L. Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 2002; 100: 3408-3414.
15. Chen W, Ford MS, Young KJ, Zhang L. Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant Proc 2003; 35: 2479-2480.
16. Young KJ, DuTemple B, Phillips MJ, Zhang L. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 2003; 171: 134-141.
17. Ford McIntyre MS, Young KJ, Gao J, Joe B, Zhang L. Cutting edge: in vivotrogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression. J Immunol 2008; 181: 2271-2275.
18. Ford MS, Chen W, Wong S, Li C, Vanama R, Elford AR etal. Peptide-activated double-negative T cel ls can prevent autoimmune type-1 diabetes development. Eur J Immunol 2007; 37: 2234-2241.
19. Chen W, Ford MS, Young KJ, Cybulsky MI, Zhang L. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003; 170: 1846-1853.
20. Allen PM, Matsueda GR, Evans RJ, Dunbar Jr JB, Marshall GR, Unanue ER. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 1987; 327: 713-715.
21. Akkaraju S, Ho WY, Leong D, Canaan K, Davis MM, Goodnow CC. A range of CD4 Tcell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997; 7: 255-271.
22. Dugas V, Beauchamp C, Chabot-Roy G, Hillhouse EE, Lesage S. Implication of the CD47 pathway in autoimmune diabetes. J Autoimmun 2010; 35: 23-32.
23. Priatel JJ, Utting O, Teh HS. TCR/self-antigen interactions drive double-negative Tcell peripheral expansion and differentiation into suppressor cells. J Immunol 2001; 167: 6188-6194.
24. He JS, Ostergaard HL. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 2007; 179: 2339-2348.
25. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
26. Zhang ZX, Stanford WL, Zhang L. Ly-6A is critical for the function of double negative regulatory T cells. Eur J Immunol 2002; 32: 1584-1592.
27. Marra LE, Zhang ZX, Joe B, Campbell J, Levy GA, Penninger J et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J Immunol 2004; 172: 1028-1035.
28. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169-175.
29. Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P etal. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 1997; 158: 4507-4513.
30. Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T et al. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules. J Immunol 2000; 165: 2841-2849.
31. Wogensen L, Huang X, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175-185.
32. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379-1384.
33. Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Li S etal. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 1994; 6: 1927-1936.
34. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HAetal. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703-707.
35. Franke A, Balschun T, Karlsen TH, Sventoraityte J, NikolausS, MayrG et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008; 40: 1319-1323.
36. Greve B, Vijayakrishnan L, Kubal A, Sobel RA, Peterson LB, Wicker LS et al. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J Immunol 2004; 173: 157-163.
37. Wu AJ, Hua H, Munson SH, McDevitt HO. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci USA 2002; 99: 12287-12292.
38. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-440.
39. Jaeckel E, von Boehmer H, Manns MP. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005; 54: 306-310.
40. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A etal. Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998; 188: 1831-1839.
41. Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. alpha/beta-T cell receptor (TCR)+CD4-CD8\(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998; 187: 1047-1056.
42. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
43. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10: 1178-1184.
44. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 Tcell receptor is expressed in all individuals by clonally expanded CD4-8\T cells. J Exp Med 1994; 180: 1171-1176.
45. Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8\T cells. J Exp Med 1997; 186: 109-120.
46. Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S, Onoe K. Cytotoxicity of fresh NK1.1+ Tcell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994; 180: 423-432.
47. Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000; 191: 661-668.
48. Baxter AG, Kinder SJ, Hammond KJ, Scollay R, Godfrey DI. Association between alphabetaTCR+CD4-CD8\T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997; 46: 572-582.
49. Chen YG, Driver JP, Silveira PA, Serreze DV. Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice. Immunogenetics 2007; 59: 705-712.
50. Esteban LM, Tsoutsman T, Jordan MA, Roach D, Poulton LD, Brooks A et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol 2003; 171: 2873-2878.
51. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8: 1313-1323.
52. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006; 6: 457-464.
53. Ho WY, Cooke MP, Goodnow CC, Davis MM. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994; 179: 1539-1549.
54. Van Parijs L, Peterson DA, Abbas AK. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998; 8: 265-274.
55. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78.